Do analysts recommend ZJYL or SIBN?

SiBone has a consensus price target of $24.17, suggesting a potential upside of 25.80%. Given SiBone's stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SiBone 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71

Which has preferable earnings and valuation, ZJYL or SIBN?

Jin Medical International has higher earnings, but lower revenue than SiBone. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 8.87 $1.19M N/A N/A SiBone $200.93M 4.24 -$18.90M -$0.34 N/A

Which has preferable valuation and earnings, AVR or ZJYL?

Jin Medical International has higher revenue and earnings than Anteris Technologies Global. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Anteris Technologies Global $1.91M 445.97 -$94.14M -$1.95 N/A Jin Medical International $20.69M 8.87 $1.19M N/A N/A

Do analysts rate ZJYL or BBNX?

Beta Bionics has a consensus target price of $20.10, indicating a potential upside of 1.93%. Given Beta Bionics' stronger consensus rating and higher probable upside, analysts plainly believe Beta Bionics is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Beta Bionics 1 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better valuation & earnings, ZJYL or BBNX?

Jin Medical International has higher earnings, but lower revenue than Beta Bionics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 8.87 $1.19M N/A N/A Beta Bionics $100.25M 8.85 -$73.20M -$1.65 N/A

Do analysts recommend INMD or ZJYL?

InMode presently has a consensus price target of $16.00, indicating a potential upside of 7.74%. Given InMode's stronger consensus rating and higher possible upside, research analysts clearly believe InMode is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMode 1 Sell rating(s) 6 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, INMD or ZJYL?

InMode has higher revenue and earnings than Jin Medical International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $370.49M 2.30 $93.83M $1.23 12.07 Jin Medical International $20.69M 8.87 $1.19M N/A N/A

Do analysts recommend VREX or ZJYL?

Varex Imaging presently has a consensus target price of $16.88, indicating a potential downside of 8.78%. Given Varex Imaging's stronger consensus rating and higher possible upside, research analysts plainly believe Varex Imaging is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Varex Imaging 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, VREX or ZJYL?

Jin Medical International has lower revenue, but higher earnings than Varex Imaging. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Varex Imaging $844.60M 0.92 -$70.30M $0.52 35.58 Jin Medical International $20.69M 8.87 $1.19M N/A N/A

Jin Medical International (ZJYL) Competitors

$2.34 -0.01 (-0.43%)

As of 08/28/2026 04:00 PM Eastern

Compare

ZJYL vs. SIBN, AVR, BBNX, INMD, and VREX

Should you buy Jin Medical International stock or one of its competitors? Jin Medical International's main competitors and comparable companies include SiBone (SIBN), Anteris Technologies Global (AVR), Beta Bionics (BBNX), InMode (INMD), and Varex Imaging (VREX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Jin Medical International compare to SiBone?

Jin Medical International (NASDAQ:ZJYL) and SiBone (NASDAQ:SIBN) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

In the previous week, SiBone had 4 more articles in the media than Jin Medical International. MarketBeat recorded 6 mentions for SiBone and 2 mentions for Jin Medical International. SiBone's average media sentiment score of 0.66 beat Jin Medical International's score of 0.30 indicating that SiBone is being referred to more favorably in the news media.

Company	Overall Sentiment
Jin Medical International	Neutral
SiBone	Positive

Jin Medical International has higher earnings, but lower revenue than SiBone.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	8.87	$1.19M	N/A	N/A
SiBone	$200.93M	4.24	-$18.90M	-$0.34	N/A

SiBone has a consensus price target of $24.17, suggesting a potential upside of 25.80%. Given SiBone's stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

Jin Medical International has a beta of 7.33, meaning that its stock price is 633% more volatile than the broader market. Comparatively, SiBone has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to SiBone's net margin of -6.85%. Jin Medical International's return on equity of 0.00% beat SiBone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
SiBone	-6.85%	-8.23%	-6.07%

98.1% of SiBone shares are held by institutional investors. 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

SiBone beats Jin Medical International on 8 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Anteris Technologies Global?

Anteris Technologies Global (NASDAQ:AVR) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

Jin Medical International has higher revenue and earnings than Anteris Technologies Global.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	445.97	-$94.14M	-$1.95	N/A
Jin Medical International	$20.69M	8.87	$1.19M	N/A	N/A

Jin Medical International has a net margin of 0.00% compared to Anteris Technologies Global's net margin of -4,619.27%. Jin Medical International's return on equity of 0.00% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-4,619.27%	-77.69%	-67.99%
Jin Medical International	N/A	N/A	N/A

Anteris Technologies Global has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.33, suggesting that its share price is 633% more volatile than the broader market.

Anteris Technologies Global currently has a consensus target price of $16.00, suggesting a potential upside of 83.07%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, research analysts clearly believe Anteris Technologies Global is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Anteris Technologies Global had 5 more articles in the media than Jin Medical International. MarketBeat recorded 7 mentions for Anteris Technologies Global and 2 mentions for Jin Medical International. Anteris Technologies Global's average media sentiment score of 1.17 beat Jin Medical International's score of 0.30 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Overall Sentiment
Anteris Technologies Global	Positive
Jin Medical International	Neutral

Summary

Anteris Technologies Global and Jin Medical International tied by winning 6 of the 12 factors compared between the two stocks.

How does Jin Medical International compare to Beta Bionics?

Jin Medical International (NASDAQ:ZJYL) and Beta Bionics (NASDAQ:BBNX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Jin Medical International has higher earnings, but lower revenue than Beta Bionics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	8.87	$1.19M	N/A	N/A
Beta Bionics	$100.25M	8.85	-$73.20M	-$1.65	N/A

In the previous week, Beta Bionics had 2 more articles in the media than Jin Medical International. MarketBeat recorded 4 mentions for Beta Bionics and 2 mentions for Jin Medical International. Beta Bionics' average media sentiment score of 0.55 beat Jin Medical International's score of 0.30 indicating that Beta Bionics is being referred to more favorably in the news media.

Company	Overall Sentiment
Jin Medical International	Neutral
Beta Bionics	Positive

Beta Bionics has a consensus target price of $20.10, indicating a potential upside of 1.93%. Given Beta Bionics' stronger consensus rating and higher probable upside, analysts plainly believe Beta Bionics is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beta Bionics	1 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50

Jin Medical International has a net margin of 0.00% compared to Beta Bionics' net margin of -61.31%. Jin Medical International's return on equity of 0.00% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Beta Bionics	-61.31%	-26.30%	-23.25%

Jin Medical International has a beta of 7.33, indicating that its share price is 633% more volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.13, indicating that its share price is 213% more volatile than the broader market.

Summary

Jin Medical International and Beta Bionics tied by winning 6 of the 12 factors compared between the two stocks.

How does Jin Medical International compare to InMode?

InMode (NASDAQ:INMD) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

InMode has higher revenue and earnings than Jin Medical International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.30	$93.83M	$1.23	12.07
Jin Medical International	$20.69M	8.87	$1.19M	N/A	N/A

InMode has a beta of 1.89, indicating that its stock price is 89% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.33, indicating that its stock price is 633% more volatile than the broader market.

InMode presently has a consensus price target of $16.00, indicating a potential upside of 7.74%. Given InMode's stronger consensus rating and higher possible upside, research analysts clearly believe InMode is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, InMode had 1 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for InMode and 2 mentions for Jin Medical International. InMode's average media sentiment score of 0.62 beat Jin Medical International's score of 0.30 indicating that InMode is being referred to more favorably in the media.

Company	Overall Sentiment
InMode	Positive
Jin Medical International	Neutral

68.0% of InMode shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

InMode has a net margin of 20.69% compared to Jin Medical International's net margin of 0.00%. InMode's return on equity of 11.99% beat Jin Medical International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
Jin Medical International	N/A	N/A	N/A

Summary

InMode beats Jin Medical International on 12 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Varex Imaging?

Varex Imaging (NASDAQ:VREX) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

Jin Medical International has lower revenue, but higher earnings than Varex Imaging.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Varex Imaging	$844.60M	0.92	-$70.30M	$0.52	35.58
Jin Medical International	$20.69M	8.87	$1.19M	N/A	N/A

Varex Imaging has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.33, suggesting that its share price is 633% more volatile than the broader market.

Varex Imaging presently has a consensus target price of $16.88, indicating a potential downside of 8.78%. Given Varex Imaging's stronger consensus rating and higher possible upside, research analysts plainly believe Varex Imaging is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Varex Imaging	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Varex Imaging has a net margin of 2.55% compared to Jin Medical International's net margin of 0.00%. Varex Imaging's return on equity of 9.19% beat Jin Medical International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Varex Imaging	2.55%	9.19%	4.13%
Jin Medical International	N/A	N/A	N/A

In the previous week, Varex Imaging had 4 more articles in the media than Jin Medical International. MarketBeat recorded 6 mentions for Varex Imaging and 2 mentions for Jin Medical International. Varex Imaging's average media sentiment score of 1.27 beat Jin Medical International's score of 0.30 indicating that Varex Imaging is being referred to more favorably in the media.

Company	Overall Sentiment
Varex Imaging	Positive
Jin Medical International	Neutral

Summary

Varex Imaging beats Jin Medical International on 8 of the 11 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZJYL vs. The Competition

Export

Metric	Jin Medical International	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$183.53M	$5.88B	$7.21B	$12.90B
Dividend Yield	N/A	1.75%	2.54%	11.28%
P/E Ratio	N/A	21.48	212.62	21.91
Price / Sales	8.87	68.66	625.86	92.63
Price / Cash	12.77	33.69	28.74	36.03
Price / Book	0.62	6.18	11.08	6.36
Net Income	$1.19M	$149.94M	$3.48B	$349.79M
7 Day Performance	-23.03%	-0.24%	0.13%	-0.80%
1 Month Performance	15.56%	6.18%	7.08%	4.13%
1 Year Performance	-83.54%	6.30%	24.67%	15.17%

Jin Medical International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZJYL Jin Medical International	0.561 of 5 stars	$2.34 -0.4%	N/A	-83.5%	$183.53M	$20.69M	N/A	245	News Coverage Short Interest Increase
SIBN SiBone	2.373 of 5 stars	$19.63 +0.5%	$24.17 +23.1%	+15.2%	$870.59M	$200.93M	N/A	350	Insider Trade
AVR Anteris Technologies Global	3.2076 of 5 stars	$8.84 -0.6%	$16.00 +81.1%	+117.4%	$861.06M	$1.91M	N/A	138	Positive News Analyst Forecast
BBNX Beta Bionics	1.1913 of 5 stars	$19.14 -1.1%	$20.10 +5.0%	+4.7%	$860.93M	$100.25M	N/A	294
INMD InMode	1.3747 of 5 stars	$14.97 -0.4%	$16.00 +6.9%	-0.6%	$860.19M	$370.49M	12.17	480

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZJYL) was last updated on 8/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jin Medical International (ZJYL) Competitors

ZJYL vs. SIBN, AVR, BBNX, INMD, and VREX

How does Jin Medical International compare to SiBone?

Summary

How does Jin Medical International compare to Anteris Technologies Global?

Summary

How does Jin Medical International compare to Beta Bionics?

Summary

How does Jin Medical International compare to InMode?

Summary

How does Jin Medical International compare to Varex Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZJYL vs. The Competition

Jin Medical International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jin Medical International (ZJYL) Competitors

ZJYL vs. SIBN, AVR, BBNX, INMD, and VREX

How does Jin Medical International compare to SiBone?

Does the media favor ZJYL or SIBN?

Which has preferable earnings and valuation, ZJYL or SIBN?

Do analysts recommend ZJYL or SIBN?

Which has more risk & volatility, ZJYL or SIBN?

Is ZJYL or SIBN more profitable?

Do institutionals & insiders have more ownership in ZJYL or SIBN?

Summary

How does Jin Medical International compare to Anteris Technologies Global?

Which has preferable valuation and earnings, AVR or ZJYL?

Is AVR or ZJYL more profitable?

Which has more volatility and risk, AVR or ZJYL?

Do analysts recommend AVR or ZJYL?

Does the media favor AVR or ZJYL?

Summary

How does Jin Medical International compare to Beta Bionics?

Which has better valuation & earnings, ZJYL or BBNX?

Does the media favor ZJYL or BBNX?

Do analysts rate ZJYL or BBNX?

Is ZJYL or BBNX more profitable?

Which has more volatility & risk, ZJYL or BBNX?

Summary

How does Jin Medical International compare to InMode?

Which has preferable earnings & valuation, INMD or ZJYL?

Which has more volatility & risk, INMD or ZJYL?

Do analysts recommend INMD or ZJYL?

Does the media refer more to INMD or ZJYL?

Do institutionals and insiders believe in INMD or ZJYL?

Is INMD or ZJYL more profitable?

Summary

How does Jin Medical International compare to Varex Imaging?

Which has stronger valuation & earnings, VREX or ZJYL?

Which has more risk and volatility, VREX or ZJYL?

Do analysts recommend VREX or ZJYL?

Is VREX or ZJYL more profitable?

Does the media favor VREX or ZJYL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZJYL vs. The Competition

Jin Medical International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools